# Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine

> **NCT07740733** · PHASE3 · COMPLETED · sponsor: **Beijing Minhai Biotechnology Co., Ltd** · enrollment: 1240 (actual)

## Conditions studied

- Tetanus
- Tetanus Vaccine

## Interventions

- **BIOLOGICAL:** Tetanus Toxoid (Adsorbed)
- **BIOLOGICAL:** Tetanus Toxoid (Adsorbed)

## Key facts

- **NCT ID:** NCT07740733
- **Lead sponsor:** Beijing Minhai Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-29
- **Primary completion:** 2024-12-23
- **Final completion:** 2024-12-23
- **Target enrollment:** 1240 (ACTUAL)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740733, "Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07740733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*